{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:21:06Z","timestamp":1784996466209,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Diasorin Inc"},{"name":"Diasorin SAP"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176411","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T18:13:29Z","timestamp":1494526409000},"page":"e0176411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-433X","authenticated-orcid":true,"given":"Geert J.","family":"Behets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Viaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Blocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"R Baron","year":"2013","journal-title":"Nat Med"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrendo.2012.36","article-title":"Arterial calcification and bone physiology: role of the bone-vascular axis","volume":"8","author":"B Thompson","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"RL van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"VM Brandenburg","year":"2013","journal-title":"BMC Nephrol"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"HZ Ke","year":"2012","journal-title":"Endocr Rev"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3109\/0886022X.2015.1077323","article-title":"Effect of SOST gene deletion on the progression of renal interstitial fibrosis in obstructive kidney injury","volume":"37","author":"LF Wang","year":"2015","journal-title":"Ren Fail"},{"key":"ref7","article-title":"The chronic kidney disease\u2014Mineral bone disorder (CKD-MBD): Advances in pathophysiology","author":"KA Hruska","year":"2017","journal-title":"Bone"},{"issue":"15","key":"ref8","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"ZC Ryan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"D Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"D Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000366449","article-title":"Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients","volume":"128","author":"P Delanaye","year":"2014","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/jc.2014-2372","article-title":"Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients","volume":"99","author":"E Ishimura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","article-title":"Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients","volume":"99","author":"M Kanbay","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"S Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"S Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Y Fang","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2215\/CJN.09470913","article-title":"Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis","volume":"9","author":"HH Malluche","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-015-3069-7","article-title":"From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD","volume":"31","author":"VM Brandenburg","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"P Evenepoel","year":"2015","journal-title":"Kidney Int"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00198-015-3127-9","article-title":"Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?","volume":"26","author":"S Pelletier","year":"2015","journal-title":"Osteoporos Int"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.V451205","article-title":"Second generation logarithmic estimates of single-pool variable volume Kt\/V: an analysis of error","volume":"4","author":"JT Daugirdas","year":"1993","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Y Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11255-015-0971-7","article-title":"Can we compare serum sclerostin results obtained with different assays in hemodialysis patients?","volume":"47","author":"RM Moyses","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfu301","article-title":"High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study","volume":"30","author":"C Drechsler","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00198-011-1806-8","article-title":"Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study","volume":"23","author":"MS Ardawi","year":"2012","journal-title":"Osteoporos Int"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1210\/jc.2011-0566","article-title":"Circulating sclerostin in disorders of parathyroid gland function","volume":"96","author":"AG Costa","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-10-0699","article-title":"Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls","volume":"163","author":"AH van Lierop","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"I Kramer","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/11.7.1292","article-title":"Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism","volume":"11","author":"I Berdud","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"SG Massry","year":"1973","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7\u201384)","volume":"95","author":"K Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"H Komaba","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"D Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2141.2009.07587.x","article-title":"Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma","volume":"145","author":"N Voorzanger-Rousselot","year":"2009","journal-title":"Br J Haematol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/ATVBAHA.109.189761","article-title":"Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis","volume":"29","author":"T Ueland","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e0125764","DOI":"10.1371\/journal.pone.0125764","article-title":"A critical role for the transient receptor potential channel type 6 in human platelet activation","volume":"10","author":"HP Vemana","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001000","article-title":"Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin","volume":"3","author":"S Lattanzio","year":"2014","journal-title":"Journal of the American Heart Association"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: Another vascular calcification inhibitor?","volume":"98","author":"KJ Claes","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1210\/jc.2012-3038","article-title":"Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes","volume":"98","author":"TC Register","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"e111703","DOI":"10.1371\/journal.pone.0111703","article-title":"Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus","volume":"9","author":"A Garcia-Martin","year":"2014","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:56:43Z","timestamp":1659016603000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176411"}},"subtitle":[],"editor":[{"given":"Yin","family":"Tintut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176411","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}